KEY INTERMEDIATES FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

The present invention relates in general to the field of organic chemistry and in particular to the preparation of N-(4-(4-fluorophenyl)-6-isopropyl-5-methylpyrimidin-2-yl)-N-methylmethanesulfonamide (I), N-(4-(4-fluorophenyl)-5-(bromomethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (II...

Full description

Saved in:
Bibliographic Details
Main Authors KOSMRLJ JANEZ, CASAR ZDENKO
Format Patent
LanguageEnglish
Published 26.01.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present invention relates in general to the field of organic chemistry and in particular to the preparation of N-(4-(4-fluorophenyl)-6-isopropyl-5-methylpyrimidin-2-yl)-N-methylmethanesulfonamide (I), N-(4-(4-fluorophenyl)-5-(bromomethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (II) and N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (III), key intermediates in preparation of Rosuvastatin.
AbstractList The present invention relates in general to the field of organic chemistry and in particular to the preparation of N-(4-(4-fluorophenyl)-6-isopropyl-5-methylpyrimidin-2-yl)-N-methylmethanesulfonamide (I), N-(4-(4-fluorophenyl)-5-(bromomethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (II) and N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide (III), key intermediates in preparation of Rosuvastatin.
Author CASAR ZDENKO
KOSMRLJ JANEZ
Author_xml – fullname: KOSMRLJ JANEZ
– fullname: CASAR ZDENKO
BookMark eNqNjLsKwkAQAK_Qwtc_LFgLSaws13OPHF5y4XYjpIpBzkqSQPx_jOAHWE0zM2u16Ic-rtT9Sg3YUigUdLEoxGB8AMkJuClnsGXwBoLn-oYsKLaEWahyDAVqqsVqdK4B1JoqwbObQ3TC30Ugb7Zq-exeU9z9uFF7Q6LzQxyHNk5j94h9fLc1Z0maJVmWnFJMj_9ZH9yfNnE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2012022091A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2012022091A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2012022091A13
Notes Application Number: US201013145783
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120126&DB=EPODOC&CC=US&NR=2012022091A1
ParticipantIDs epo_espacenet_US2012022091A1
PublicationCentury 2000
PublicationDate 20120126
PublicationDateYYYYMMDD 2012-01-26
PublicationDate_xml – month: 01
  year: 2012
  text: 20120126
  day: 26
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies LEK PHARMACEUTICALS D.D
CASAR ZDENKO
KOSMRLJ JANEZ
RelatedCompanies_xml – name: KOSMRLJ JANEZ
– name: CASAR ZDENKO
– name: LEK PHARMACEUTICALS D.D
Score 2.8385766
Snippet The present invention relates in general to the field of organic chemistry and in particular to the preparation of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title KEY INTERMEDIATES FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120126&DB=EPODOC&locale=&CC=US&NR=2012022091A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5DRX3TqfhjSkDpW3HralYfhmRpSqdbW5p0bE-zqR0I0g1X8d_3Ujfd06DQJmmP5Mrd17skXxG6AwzOWiprmjMnJabtENtUbSc1wRWm5O0xg48OnRoYBsRP7Ofxw7iGPtZ7YSqe0O-KHBEsKgN7Lyt_vfhPYrnV2srlvXqHqvmTJ7uusYqOW_oghtvr8ih0Q2Yw1k2EEcS_bZYF6EghVtrVxFuaaZ-PenpfymITVLwjtBeBvKI8RrW8qKMDtv73Wh3tD1dT3nC5sr7lCXp94RNccdhqUkYqucAQw2HpcywmAZxEX-DQw3EokhEVksp-gOGGyKfxkDKeSE1-MJhgyhiPJO0N4EE6kEKLiHnonaJbj0vmm9DV6Z9mponYHFf7DO0U8yI_R7hjAwzbrTSzVNNu5wrewWzW0Vht2cRpqgvU2CbpcnvzFTrURZ2JsEgD7ZSfX_k1YHOpbiqV_gCuDIkU
link.rule.ids 230,308,780,885,25564,76547
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivNNp-LH1IDSt-LW1a4-DMnSlM71iyYd29NsaweCdMNV_Pe91E33NAg09JKjSbn8cpfkF4TuAYOzTpq11bmZGKpuGrqads1EhaEwMd6eMph0yNCA5xtOrL9MHic19LE5C1PxhH5X5IhgURnYe1mN18v_IJZV7a1cPaTv8GrxbIu-pay9445MhmIN-iwMrIAqlPZjrvjRr0zTAB0J-Ep7PXnnrpw8jQfyXMpyG1TsI7Qfgr6iPEa1vGiiBt3cvdZEB956yRuya-tbnaDXEZviisNWkjISwTgGHw4Lh2E-9eHBhxwHNo4CHo8JF0QMfQwFQodEHqEsFpL8wJ1iQikLBRm4UJG4gksVEQvsU3RnM0EdFT519tczs5hvt6t7hurFosjPEe7pAMN6J8m0tK138xT-wXzek1it6YbZTi9Qa5emy93iW9RwhOfO3KE_ukKHUiSjEprRQvXy8yu_Bpwu05uqe38ARiKMBQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=KEY+INTERMEDIATES+FOR+THE+SYNTHESIS+OF+ROSUVASTATIN+OR+PHARMACEUTICALLY+ACCEPTABLE+SALTS+THEREOF&rft.inventor=KOSMRLJ+JANEZ&rft.inventor=CASAR+ZDENKO&rft.date=2012-01-26&rft.externalDBID=A1&rft.externalDocID=US2012022091A1